TORONTO, Jan. 04, 2023 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) is pleased to announce a five-year licensing agreement of VitalHub subsidiary Intouch with Health’s (Intouch) Patient Journey Platform by Wirral University Teaching Hospital NHS Foundation Trust (“Wirral” or the “Trust”).
The Trust provides healthcare for people of the Wirral Peninsula and the surrounding areas of North West England and North Wales, and is one of the biggest and busiest acute NHS trusts in the North West, serving a population in excess of 320,000 people. Prior to this contract, Wirral was an existing VitalHub subsidiary (Jayex) customer, and has opted to extend and expand their engagement with the Company. This expansion contract will provide the Trust with access to the Company’s robust suite of Patient Journey solutions, including: Flow Manager, Check-in, Patient Calling, Wait Time Manager, Activity Manager, eOutcomes, Mobile Appointment Manager, Walk-in Manager, Room and Resource Manager, Wayfinding, Virtual Clinics, HL7 integration to PAS.
The Intouch with Health Patient Journey Platform enables NHS Trusts and healthcare organizations to manage entire patient workflows and optimize flow in outpatient care in an efficient manner. Processing approximately 56% of all NHS outpatient attendances, the Intouch Platform processes 55 million outpatient appointments annually, utilizing real time data and integrated blended pathways to improve patient flow and support more effective patient care.
“We are thrilled to be deepening our relationship Wirral University Teaching Hospital Foundation Trust,” said Dan Matlow, CEO of VitalHub Corp. “The Intouch suite of services offers health systems powerful tools to manage the patient journey, and will provide meaningful operational improvements to the Trust. We value the ongoing market traction, contract renewals and expansions we are seeing across the UK marketplace and beyond. We look forward to an exciting year ahead as we continue to execute on our strategic growth initiatives.”
ABOUT WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FOUNDATION TRUST
Wirral University Teaching Hospital NHS Foundation Trust is an NHS Foundation Trust, providing healthcare for people of the Wirral Peninsula and the surrounding areas of North West England and North Wales; a population in excess of 320,000 people. Wirral is one of the biggest and busiest acute NHS trusts in the North West. The Trust has been recognized by numerous national awards in areas including dermatology, dementia, patient experience, patient safety, scientific innovation and staff engagement.
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes. VitalHub develops mission-critical technology solutions for Health and Human Services providers in the Mental Health (Child, Youth & Adult), Long-Term Care, Home Health, Community & Social Services and Acute Care sectors.
VitalHub develops technologies in two primary categories: Patient Flow, Operational Visibility & Patient Journey Optimization solutions; and Electronic Health Record, Case Management, Care Coordination & Optimization solutions. The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing a strategic M&A plan. Currently VitalHub serves more than 600 clients across Canada, USA, UK, Australia, New Zealand, the Middle East, and Europe.
VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The VitalHub team comprises more than 200 team members globally. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol “VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
CONTACT INFORMATION
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@vitalhub.com
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE:…
Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood…
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC /…
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis…
CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio…